NEWS & EVENTS
ACE’s new report shows there is a worrying trend that healthcare commissioners are not aware of how many people in their locality have one of the early warning signs of being at an increased risk of a stroke, atrial fibrillation (AF). With less than half of clinical commissioning groups (CCGs) having assessed the prevalence of the condition in their area, and almost two thirds not having assessed the cost of their anticoagulation service.
CLICK ON WORDS ABOVE AND HELP US BY COMPLETING THE QUESTIONNAIRE Help develop national clinical guidance for the management of patients needing dental treatment and who are taking anticoagulant or antiplatelet drugs. What is the aim of this questionnaire? The aim of this questionnaire is to explore patients’: • Views of their experiences of dental treatment in primary care when taking anticoagulant drugs. • Concerns they may have that might be addressed by the new guidance.
Help us raise awareness of the NICE recommendation for self-monitoring for people on warfarin and to campaign for the monitors to be available on prescription. Join the SelfieChek campaign and post your comments and a selfiechek photo on our Facebook page www.facebook.com/selfiechek
Access to the new anticoagulants: A joint statement from Anticoagulation Europe & Lifeblood: The Thrombosis Charity
Access to the new anticoagulants: A joint statement from Anticoagulation Europe & Lifeblood: The Thrombosis Charity Lifeblood and Anticoagulation Europe are both very concerned that the NICE recommendations that there should be equal access to VKAs (warfarin) and NOACs in the NICE approved indications are not being implemented. The NHS constitution states that patients should not be denied access to NICE approved drugs.
24th Sept 2014 The National Institute of Health and Care Excellence (NICE) has recommended self-monitoring of INR levels for people with atrial fibrillation and people with replacement heart valves - if the person prefers this form of testing and if the person or their carer is both physically and cognitively able to self-monitor effectively.
The National Institute for Health and Care Excellence (NICE) has revised its guidance on Atrial Fibrillation. It says that anticoagulation may be with Apixaban, Dabigatran Etixialte, Rivaroxaban or a Vitamin K Antagonist (warfarin). It also states that aspirin should no longer be used as a sole therapy for stroke prevention in AF.
Welcome to Anticoagulation Europe
Can you help us?
We are looking for patients living in the West of England to help develop patient information for a project called "Don't Debate - Anticoagulate". This is being developed by the West of England Academic Health Science Network to help prevent blood clots and strokes by getting people who should be on anticoagulation therapy adequately treated.
Please email us at firstname.lastname@example.org or phone 0208 289 6875 to learn more.
We rely on donations and subscriptions so please consider joining or making a donation to enable us to coninue our work.
You can donate by clicking on to the link to right of this page. For easy ways to help us raise funds, at no cost to you, click on Give as You Live at the bottom of the page.
Raise money for ACE by getting a quote for your car insurance. If you then take out a policy ACE gets £10 donated at no cost to you. Click on the link below to go to the justgiving page and then click for a quote. Monkey has over 120 companies to quote you from.
Sign our E-petition to get the government to debate free prescriptions for long term users of anticoagulation therapy
This petition replaces the first one which has expired. If you signed the first one you will need to sign again on this one. Please support us.